CEPMED

  • About Cepmed
    • Leadership
    • Press Releases
    • Board of Directors
    • Founding Members
    • Annual Reports
    • Events
  • Cepmed Activities
    • Public-Private Partnerships
    • Commercialization
    • Knowledge Translation
      • Physician Expert Panels
      • National Physician Survey
      • Economic Forum of the Americas 2010
  • About Personalized Medicine
    • Personalized Medicine 101
    • Reports and Articles
    • News and Developments
  • Personalized Medicine Portal
    • For Cancer
    • For Other Conditions
    • For Medication
    • Tests A-Z
  • Home
  • Contact Us
  • Français
  • Print
  • Share
    • del.icio.us del.icio.us
    • StumbleUpon StumbleUpon
    • digg digg
    • Twitter Twitter
    • Facebook Facebook
    • Google Google
    • Linked In Linked In
  • Send

For Other Conditions

Follow the links below to learn about how genetic testing can be used to personalize or optimize medical treatment and drug therapy, when testing is appropriate and access to testing in your province.

  • Long QT SyndromeAccess Testing
  • Familial Hypercholesterolemia, APOB/LDLRAccess Testing
  • Hypertrophic CardiomyopathyAccess Testing
  • Warfarin Sensitivity,CYP2C9/VKORC1Access Testing
  • Clopidogrel Drug Response, CYP2C19Access Testing
  • Statin Drug Response, KIF6Access Testing
  • Antidepressant Drug Response, CYP2D6/CYP2C19Access Testing
  • Carbamazepine Drug Response, HLA-B*1502Access Testing
  • Abacavir Hypersensitivity Reaction, HLA-B*5701Access Testing
  • Maraviroc Drug Response, ccr5 TropismAccess Testing
  • Celiac Disease, HLA-DQ2/HLA-DQ8 Access Testing
  • Crohns Disease, NOD2/CARD15Access Testing
  • Methotrexate Drug Response, MTHFRAccess Testing
  • Alpha-1 Antitrypsin Deficiency, PI*S/PI*ZAccess Testing

Copyright © 2010 - 2011 CEPMED    Terms & Conditions • Site Map